Cargando…
Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats
Non-alcoholic fatty liver disease (NAFLD) affects more than 70% of patients with type 2 diabetes mellitus (T2DM) and has become one of the most common metabolic liver diseases worldwide. To date, treatments specifically targeting NAFLD do not exist. Oxidative stress and insulin resistance have been...
Autores principales: | Polce, Simran Alexandria, Burke, Cameron, França, Lucas Martins, Kramer, Benjamin, Paes, Antonio Marcus de Andrade, Carrillo-Sepulveda, Maria Alicia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986411/ https://www.ncbi.nlm.nih.gov/pubmed/29693586 http://dx.doi.org/10.3390/nu10050531 |
Ejemplares similares
-
Ellagic acid Alleviates hepatic ischemia–reperfusion injury in C57 mice via the Caspase-1-GSDMD pathway
por: Wang, Hao, et al.
Publicado: (2022) -
Ellagic acid alleviates adjuvant induced arthritis by modulation of pro- and anti-inflammatory cytokines
por: Allam, Gamal, et al.
Publicado: (2017) -
The Effect of Ellagic Acid on Hepatic Lipid Metabolism and Antioxidant Activity in Mice
por: Xu, Qiuying, et al.
Publicado: (2021) -
Syzygium cumini (L.) skeels: a prominent source of bioactive molecules against cardiometabolic diseases
por: Chagas, Vinicyus Teles, et al.
Publicado: (2015) -
Antidiabetic effects of novel ellagic acid nanoformulation: Insulin-secreting and anti-apoptosis effects
por: Harakeh, Steve, et al.
Publicado: (2020)